ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,487, issued on Jan. 27, was assigned to The Research Foundation for The State University of New York (Amherst, N.Y.).
"Compounds for use as iron(III) MRI contrast agents" was invented by Janet R. Morrow (Williamsville, N.Y.), Eric M. Snyder (Williamsville, N.Y.) and Didar Asik (Buffalo, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are macrocyclic compounds and compounds with two or more macrocyclic groups, iron coordinated macrocyclic compounds, and iron coordinated compounds with two or more macrocyclic groups. The iron is high-spin iron(III). The iron coordinated compounds may exhibit a negative redox potential (e.g., relative to a...